Intrajejunal levodopa infusion in advanced Parkinson's disease: long-term effects on motor and non-motor symptoms and impact on patient's and caregiver's quality of life

Anna Rita Bentivoglio, Alfonso Fasano, L Ricciardi, F Lena, Nicola Modugno

Risultato della ricerca: Contributo in rivistaArticolo in rivista

35 Citazioni (Scopus)

Abstract

Continuous infusion of intrajejunal levodopa/carbidopa gel (CIILG) for advanced Parkinson's disease (PD) has been proved to be beneficial on motor complications, non-motor symptoms and quality of life in the short-term follow-up. Aim of this two-center, retrospective, open-label study was to evaluate the long-term effect of CIILG on patients' condition and caregivers' quality of life.
Lingua originaleEnglish
pagine (da-a)79-89
Numero di pagine11
RivistaEuropean Review for Medical and Pharmacological Sciences
Volume16
Stato di pubblicazionePubblicato - 2012

Keywords

  • Adult
  • Aged
  • Antiparkinson Agents
  • Caregivers
  • Cohort Studies
  • Disability Evaluation
  • Female
  • Humans
  • Infusions, Parenteral
  • Jejunum
  • Levodopa
  • Male
  • Middle Aged
  • Neuropsychological Tests
  • Parkinson Disease
  • Quality of Life
  • Retrospective Studies
  • Treatment Outcome

Fingerprint Entra nei temi di ricerca di 'Intrajejunal levodopa infusion in advanced Parkinson's disease: long-term effects on motor and non-motor symptoms and impact on patient's and caregiver's quality of life'. Insieme formano una fingerprint unica.

Cita questo